CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 420 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,054 | -17.9% | 1,984 | +1.6% | 0.00% | -50.0% |
Q2 2023 | $109,641 | +21.9% | 1,953 | -1.8% | 0.00% | +100.0% |
Q1 2023 | $89,917 | +10.2% | 1,988 | -1.0% | 0.00% | 0.0% |
Q4 2022 | $81,625 | -34.7% | 2,008 | +5.0% | 0.00% | -50.0% |
Q3 2022 | $125,000 | +5.9% | 1,913 | -1.6% | 0.00% | 0.0% |
Q2 2022 | $118,000 | +4.4% | 1,944 | +8.2% | 0.00% | 0.0% |
Q1 2022 | $113,000 | +113.2% | 1,796 | +155.5% | 0.00% | +100.0% |
Q4 2021 | $53,000 | -55.1% | 703 | -33.1% | 0.00% | -50.0% |
Q3 2021 | $118,000 | -58.9% | 1,051 | -40.6% | 0.00% | -60.0% |
Q2 2021 | $287,000 | -100.0% | 1,770 | -78.7% | 0.01% | -44.4% |
Q1 2021 | $1,012,330,000 | +722992.9% | 8,308 | +806.0% | 0.01% | +200.0% |
Q4 2020 | $140,000 | +351.6% | 917 | +145.8% | 0.00% | +200.0% |
Q3 2020 | $31,000 | +40.9% | 373 | +24.3% | 0.00% | 0.0% |
Q2 2020 | $22,000 | +83.3% | 300 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -33.3% | 300 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $18,000 | +50.0% | 300 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $13,000 | +116.7% | 300 | +200.0% | 0.00% | – |
Q2 2018 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |